⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10523738 | 0.76 | — | — | |
| SCHEMBL20876138 | 0.74 | — | — | |
| SCHEMBL2949167 | 0.73 | — | — | |
| SCHEMBL28367673 | 0.69 | CA2 (0.41) | — | |
| SCHEMBL7290545 | 0.69 | CA1 (0.37) | — | |
| SCHEMBL9343213 | 0.67 | — | — | |
| SCHEMBL11141576 | 0.65 | CA2 (0.36) | — | |
| SCHEMBL224724 | 0.65 | — | — | |
| SCHEMBL27956515 | 0.65 | — | — | |
| SCHEMBL6200806 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008133344-A2 | PIPERIDINE DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-11-06 | — | — | WO | claimed |
| US-20080275085-A1 | Piperidine derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-11-06 | — | — | US | claimed |
| US-20050272646-A1 | Streptogramin antibiotics | MCMASTER UNIVERSITY | 2005-12-08 | — | — | US | claimed |
| EP-4262879-A1 | OLIGOMERIC COMPOUNDS BINDING SPECIFICALLY TO PROTEOGLYCANS | Phi Pharma SA (CH) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022129627-A1 | OLIGOMERIC COMPOUNDS BINDING SPECIFICALLY TO PROTEOGLYCANS | PHI PHARMA SA (CH) | 2022-06-23 | — | — | WO | disclosed |
| EP-2426139-B1 | CXCR4 antagonist and use thereof | BIOKINE THERAPEUTICS LTD (IL) | 2014-10-01 | — | — | EP | disclosed |
| WO-2013162760-A1 | NOVEL CYCLOTIDES WITH ANTICANCER ACTIVITY | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2013-10-31 | — | — | WO | disclosed |
| CN-101801995-B | Antibacterial peptide | AMP THERAPEUTICS GMBH & CO KG | 2013-10-30 | — | — | CN | disclosed |
| US-8410059-B2 | CXCR4 antagonist and use thereof | BIOKINE THERAPEUTICS LTD. (IL) | 2013-04-02 | — | — | US | disclosed |
| EP-1541585-B1 | CXCR4 ANTAGONIST AND USE THEREOF | BIOKINE THERAPEUTICS LTD (IL) | 2013-01-30 | — | — | EP | disclosed |
| EP-1732609-B1 | CONJUGATES OF HYDROXYALKYL STARCH AND A PROTEIN | FRESENIUS KABI DE GMBH (DE) | 2012-07-11 | — | — | EP | disclosed |
| US-7169756-B2 | Streptogramin antibiotics | MCMASTER UNIVERSITY (CA) | 2007-01-30 | — | — | US | disclosed |
| EP-1732609-A2 | CONJUGATES OF HYDROXYALKYL STARCH AND A PROTEIN | Fresenius Kabi Deutschland GmbH (DE) | 2006-12-20 | — | — | EP | disclosed |
| US-20060264378-A1 | Cxcr4 antagonist and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-11-23 | — | — | US | disclosed |
| US-20060134691-A1 | Labeling methodology comprising oligopeptides | AUER MANFRED | 2006-06-22 | — | — | US | disclosed |
| US-20050272646-A1 | Streptogramin antibiotics | MCMASTER UNIVERSITY | 2005-12-08 | — | — | US | disclosed |
| WO-2005092391-A2 | CONJUGATES OF HYDROXYALKYL STARCH AND A PROTEIN | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2005-10-06 | — | — | WO | disclosed |
| EP-1541585-A1 | CXCR4 ANTAGONIST AND USE THEREOF | Fujii, Nobutaka (JP) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004051270-A2 | LABELING METHODOLOGY COMPRISING OLIGOPEPTIDES | NOVARTIS AG (CH) | 2004-06-17 | — | — | WO | disclosed |
| WO-1999040435-A1 | PROTEIN FOLDING INHIBITORS | NETZER WILLIAM J (US) | 1999-08-12 | — | — | WO | disclosed |